Clarkston Consulting and 4G Clinical announced a partnership to enhance value in clinical trial strategy and operations for their respective clients in the pharmaceutical and biotech industries.
This collaboration enables life sciences businesses to leverage 4G's breakthrough RTSM technologies and Clarkston's recognized services in clinical supply chain operations and management as needed to accelerate the speed of drugs to market, optimize the clinical supply chain, and confidently manage increasing complexities in trial design and execution.
"The industry is changing. As clinical trial complexity increases, the underlying technologies and capabilities that support the journey of a drug to market must evolve with it. This partnership allows both 4G and Clarkston to arm our clients with the most innovative capabilities on the market – enabling better outcomes for the patient and the business," said 4G Clinical CEO Dave Kelleher.
The partnership between 4G Clinical and Clarkston Consulting aims to create a comprehensive client experience as businesses in life sciences industries transform their clinical operations. Clarkston and 4G will also co-author industry reports and white papers on the latest trends, drivers and strategies impacting clinical trial professionals.
"The needs of patients and providers are demanding new capabilities to deliver life-saving therapies in a more cost-conscious way. 4G has developed technology that when partnered with Clarkston's consulting capabilities will optimize both patient and business outcomes. Our consultants have decades of industry and functional expertise to operationalize that tech for rapid ROI," said Tom Finegan, CEO of Clarkston.